JP2022513331A5 - - Google Patents
Info
- Publication number
- JP2022513331A5 JP2022513331A5 JP2021543565A JP2021543565A JP2022513331A5 JP 2022513331 A5 JP2022513331 A5 JP 2022513331A5 JP 2021543565 A JP2021543565 A JP 2021543565A JP 2021543565 A JP2021543565 A JP 2021543565A JP 2022513331 A5 JP2022513331 A5 JP 2022513331A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- chain variable
- antibody according
- variable domain
- domain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB201816210 | 2018-10-04 | ||
| GB1816210.7 | 2018-10-04 | ||
| PCT/EP2019/076772 WO2020070225A1 (en) | 2018-10-04 | 2019-10-02 | Humanised anti-n-truncated amyloid beta monoclonal antibody |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022513331A JP2022513331A (ja) | 2022-02-07 |
| JP2022513331A5 true JP2022513331A5 (enExample) | 2022-10-06 |
| JP7610515B2 JP7610515B2 (ja) | 2025-01-08 |
Family
ID=68136417
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021543565A Active JP7610515B2 (ja) | 2018-10-04 | 2019-10-02 | ヒト化抗Ｎ短縮型アミロイドβモノクローナル抗体 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US12297261B2 (enExample) |
| EP (1) | EP3861023A1 (enExample) |
| JP (1) | JP7610515B2 (enExample) |
| KR (1) | KR102862077B1 (enExample) |
| CN (1) | CN113056480B (enExample) |
| AU (1) | AU2019354714B9 (enExample) |
| BR (1) | BR112021006153A2 (enExample) |
| EA (1) | EA202190954A1 (enExample) |
| IL (1) | IL281979B2 (enExample) |
| MX (1) | MX2021003867A (enExample) |
| SG (1) | SG11202102765RA (enExample) |
| WO (1) | WO2020070225A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111201030B (zh) | 2017-07-25 | 2024-11-01 | 真和制药有限公司 | 通过阻断tim-3和其配体的相互作用治疗癌症 |
| KR20210124308A (ko) | 2019-01-30 | 2021-10-14 | 트루바인딩 아이엔씨. | 항-gal3 항체 및 이의 용도 |
| CN115698060A (zh) | 2020-03-10 | 2023-02-03 | 生命爱科 | 环肽 |
| MX2022014786A (es) | 2020-05-26 | 2023-01-16 | Truebinding Inc | Metodos para tratar enfermedades inflamatorias mediante el bloqueo de galectina-3. |
| WO2024133925A1 (en) | 2022-12-22 | 2024-06-27 | Bioarctic Ab | Antibody which binds to abetape3 |
| WO2025262228A1 (en) | 2024-06-20 | 2025-12-26 | Bioarctic Ab | Bispecific binding molecule |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US474900A (en) | 1892-05-17 | William byrnes | ||
| US4704362A (en) | 1977-11-08 | 1987-11-03 | Genentech, Inc. | Recombinant cloning vehicle microbial polypeptide expression |
| EP0279582A3 (en) | 1987-02-17 | 1989-10-18 | Pharming B.V. | Dna sequences to target proteins to the mammary gland for efficient secretion |
| US5633076A (en) | 1989-12-01 | 1997-05-27 | Pharming Bv | Method of producing a transgenic bovine or transgenic bovine embryo |
| US5827690A (en) | 1993-12-20 | 1998-10-27 | Genzyme Transgenics Corporatiion | Transgenic production of antibodies in milk |
| HUE033325T2 (en) * | 2007-01-05 | 2017-11-28 | Univ Zuerich | Anti-beta-amyloid binder antibodies and their use |
| CN101883792B (zh) | 2007-10-29 | 2014-08-27 | 基因创新有限公司 | 特异于β-淀粉状蛋白肽的新抗体以及其用作诊断剂或药物的用途 |
| US8795664B2 (en) | 2010-06-04 | 2014-08-05 | Georg-August-Universität Göttingen Stiftung Öffentlichen Rechts, Universitätsmedizin | Monoclonal antibodies targeting amyloid beta oligomers |
| DK3269736T3 (da) * | 2012-05-10 | 2020-01-13 | Georg August Univ Goettingen Stiftung Oeffentlichen Rechts Univsmedizin | Konformationsspecifikke antistoffer mod oligomerer af amyloid beta |
| WO2015173133A1 (en) | 2014-05-12 | 2015-11-19 | Chiesi Farmaceutici S.P.A. | Formulations and methods of treating alzheimer's disease and other proteinopathies by combination therapy |
| NZ739181A (en) * | 2015-07-16 | 2023-05-26 | Vivoryon Therapeutics N V | Anti-pyroglutamated amyloid beta humanized antibodies |
| CN111518206B (zh) * | 2019-02-01 | 2022-03-29 | 长春金赛药业有限责任公司 | 人源化抗Aβ单克隆抗体及其应用 |
| CN115698060A (zh) * | 2020-03-10 | 2023-02-03 | 生命爱科 | 环肽 |
-
2019
- 2019-10-02 KR KR1020217012796A patent/KR102862077B1/ko active Active
- 2019-10-02 SG SG11202102765RA patent/SG11202102765RA/en unknown
- 2019-10-02 JP JP2021543565A patent/JP7610515B2/ja active Active
- 2019-10-02 MX MX2021003867A patent/MX2021003867A/es unknown
- 2019-10-02 AU AU2019354714A patent/AU2019354714B9/en active Active
- 2019-10-02 EA EA202190954A patent/EA202190954A1/ru unknown
- 2019-10-02 WO PCT/EP2019/076772 patent/WO2020070225A1/en not_active Ceased
- 2019-10-02 IL IL281979A patent/IL281979B2/en unknown
- 2019-10-02 US US17/282,592 patent/US12297261B2/en active Active
- 2019-10-02 CN CN201980065883.5A patent/CN113056480B/zh active Active
- 2019-10-02 BR BR112021006153-3A patent/BR112021006153A2/pt unknown
- 2019-10-02 EP EP19782593.8A patent/EP3861023A1/en active Pending